Cargando…
Cyclophosphamide/fludarabine/rituximab: Prolonged viral shedding and protracted COVID-19: case report
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8872870/ http://dx.doi.org/10.1007/s40278-022-10582-8 |
Ejemplares similares
-
Cyclophosphamide/doxorubicin/prednisone: Prolonged COVID-19 viral shedding, neutropenia and thrombocytopenia: case report
Publicado: (2021) -
Bendamustine/rituximab: Prolonged SARS-CoV-2 viral shedding : case report
Publicado: (2022) -
Cyclophosphamide/rituximab: COVID-19 infection: case report
Publicado: (2021) -
Rituximab and Fludarabine or Cyclophosphamide Combination Treatment for Older Waldenström Macroglobulinemia Patients
por: Xu, XiaoWei, et al.
Publicado: (2013) -
Simultaneous clinical resolution of focal segmental glomerulosclerosis associated with chronic lymphocytic leukaemia treated with fludarabine, cyclophosphamide and rituximab
por: Arampatzis, Spyridon, et al.
Publicado: (2011)